Lexeo Therapeutics, Inc. Common Stock (LXEO) is a publicly traded Healthcare sector company. As of August 5, 2026, LXEO trades at $4.54 with a market cap of $329.79M and a P/E ratio of -2.37. LXEO moved +3.40% today. Year to date, LXEO is -55.59%; over the trailing twelve months it is -7.55%. Its 52-week range spans $1.45 to $10.99. Analyst consensus is strong buy with an average price target of $15.75. Rallies surfaces LXEO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for LXEO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $4.54 |
| Market Cap | $329.79M |
| P/E Ratio | -2.37 |
| EPS | $-1.86 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.99 |
| 52-Week Low | $1.45 |
| Volume | 41.41K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-99.96M |
| Gross Margin | 0.00% |
4 analysts cover LXEO: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $15.75.